dihydroergotamine has been researched along with Deep Vein Thrombosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gelfand, AA; Goadsby, PJ; Patniyot, IR; Tso, AR | 1 |
Adekoya-Cole, TO; Enweluzo, GO; Giwa, SO; Obalum, DC; Ogo, CN | 1 |
1 review(s) available for dihydroergotamine and Deep Vein Thrombosis
Article | Year |
---|---|
Deep vein thrombosis: risk factors and prevention in surgical patients.
Topics: Anticoagulants; Aspirin; Awareness; Clinical Competence; Cyclooxygenase Inhibitors; Dextrans; Dihydroergotamine; Fibrinolytic Agents; Heparin; Humans; Nigeria; Postoperative Complications; Risk Factors; Vasoconstrictor Agents; Venous Thrombosis; Warfarin | 2009 |
1 other study(ies) available for dihydroergotamine and Deep Vein Thrombosis
Article | Year |
---|---|
Increased rate of venous thrombosis may be associated with inpatient dihydroergotamine treatment.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Catheters, Indwelling; Child; Dihydroergotamine; Female; Humans; Incidence; Inpatients; Lidocaine; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Tertiary Care Centers; Venous Thrombosis; Young Adult | 2017 |